Clinical Laserthermia Systems AB (FRA:LS60) Beta: 22.4220 (As of Jun. 24, 2026)


FRA:LS60 Clinical Laserthermia Systems AB FRA:LS60
36 GF Score
Price €0.27
GF Value €0.29
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Clinical Laserthermia Systems AB Beta?

Clinical Laserthermia Systems AB FRA:LS60 -2.91% 36 Beta is 22.4220 as of Jun. 24, 2026. GuruFocus rates FRA:LS60 with a GF Score™ of 36/100 and a GF Value™ of €0.29 (Fairly Valued). The stock has 4 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-24), Clinical Laserthermia Systems AB's Beta is 22.4220.


Clinical Laserthermia Systems AB  (FRA:LS60) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Clinical Laserthermia Systems AB Beta Related Terms


Clinical Laserthermia Systems AB Beta Historical Data

* Premium members only.

The historical data trend for Clinical Laserthermia Systems AB's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Clinical Laserthermia Systems AB Beta Chart

Clinical Laserthermia Systems AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 1.50 17.25 -7.05 -14.96

Clinical Laserthermia Systems AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.88 20.59 23.43 -14.96 23.53

FRA:LS60 vs ABT, SYK, MDT: Beta Comparison

For the Medical Devices subindustry, Clinical Laserthermia Systems AB's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Clinical Laserthermia Systems AB Beta vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Clinical Laserthermia Systems AB's Beta distribution charts can be found below:

* The bar in red indicates where Clinical Laserthermia Systems AB's Beta falls into.


FRA:LS60
36GF Score
Clinical Laserthermia Systems AB FRA:LS60
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Clinical Laserthermia Systems AB Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 22.4220 mean?
Clinical Laserthermia Systems AB (FRA:LS60) has a Beta of 22.4220 as of Jun. 24, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Clinical Laserthermia Systems AB and its competitors.
Is Clinical Laserthermia Systems AB's Beta too high?
Clinical Laserthermia Systems AB's current Beta is 22.4220. Overall, Clinical Laserthermia Systems AB has a GF Score™ of 36/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Clinical Laserthermia Systems AB's Beta compare to ABT and SYK?
Clinical Laserthermia Systems AB's Beta of 22.4220 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Medical Devices & Instruments company?
A good Beta depends on the Medical Devices & Instruments industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Clinical Laserthermia Systems AB and its competitors. Clinical Laserthermia Systems AB's current Beta is 22.4220. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clinical Laserthermia Systems AB stock overvalued right now?
Based on GuruFocus' analysis, Clinical Laserthermia Systems AB (FRA:LS60) is currently considered Fairly Valued. The stock's GF Value™ is €0.29, compared to a current price of €0.27 — trading 7.9% below its estimated fair value. The current Beta is 22.4220. Clinical Laserthermia Systems AB's overall GF Score™ is 36/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Clinical Laserthermia Systems AB (FRA:LS60), the current Beta is 22.4220 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Clinical Laserthermia Systems AB (FRA:LS60) Overvalued in 2026?

Based on GuruFocus' analysis, Clinical Laserthermia Systems AB stock appears to be undervalued. The current stock price of €0.27 is trading 7.9% below its estimated GF Value™ of €0.29. GuruFocus considers Clinical Laserthermia Systems AB to be Fairly Valued.

Key valuation signals for FRA:LS60:

  • Beta: 22.4220
  • GF Value™: €0.29 vs. price of €0.27 (7.9% below fair value)
  • GF Score™: 36/100 with 4 warning signs

No single metric tells the full story. See the FRA:LS60 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Clinical Laserthermia Systems AB Business Description

Other Exchanges CLS B:Sweden
Address Scheelevagen 2, Medicon village, Lund, SWE, 223 81
Clinical Laserthermia Systems AB develops and sells single-use products used during each treatment procedure of treatment of solid tumors cancers. Its products include Thermal Therapy System, Mobile Laser Unit, Laser Applicator Non-cooled and Tissue Temp Probe.
36GF Score

Get the complete analysis for FRA:LS60

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.27
Price
€0.29
GF Value